Carcinoid Heart Disease: How to Diagnose and Treat in 2020?

Clinical Medicine Insights. Cardiology
Barbara BoberJacek Bil

Abstract

Neuroendocrine tumors (NETs, originally termed "carcinoids") create a relatively rare group of neoplasms with an approximate incidence rate of 2.5 to 5 cases per 100 000 persons. Roughly 30% to 40% of subjects with NETs develop carcinoid syndrome (CS), and 20% to 50% of subjects with CS are diagnosed with carcinoid heart disease (CaHD). The long-standing exposure to high serum serotonin concentration is one of the crucial factors in CaHD development. White plaque-like deposits on the endocardial surface of heart structures with valve leaflets and subvalvular apparatus thickening (fused and shortened chordae; thickened papillary muscles) are characteristic for CaHD. NT pro-BNP and 5-hydroxyindoleacetic acid are the 2 most useful screening markers. Long-acting somatostatin analogs are the standard of care in symptoms control. They are also the first-line treatment for tumor control in subjects with a metastatic somatostatin receptor avid disease. In cases refractory to somatostatin analogs, several options are available. We can increase a somatostatin analog to off-label doses, add telotristat ethyl or administer peptide receptor radionuclide therapy. Cardiac surgery, which mainly involves valve replacement, is presently the most...Continue Reading

References

Oct 1, 1985·The American Journal of Clinical Nutrition·J M Feldman, E M Lee
Feb 1, 1995·Journal of the American College of Cardiology·H M ConnollyL K Kvols
Oct 13, 1998·Journal of the American College of Cardiology·W D DenneyB F Byrd
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J RubinL Anthony
Jun 20, 2001·The British Journal of Surgery·G WestbergK Caidahl
Mar 15, 2003·The New England Journal of Medicine·Jacob E MøllerPatricia A Pellikka
Nov 16, 2005·Circulation·Jacob E MøllerHeidi M Connolly
Jan 24, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Marianne E PavelTobias Lohmann
Mar 27, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·Christos ToumpanakisMartyn E Caplin
May 15, 2007·Progress in Cardiovascular Diseases·Alain M BernheimPatricia A Pellikka
Dec 12, 2007·Circulation·Sanjeev BhattacharyyaMartyn E Caplin
Sep 23, 2008·The American Journal of Cardiology·Sanjeev BhattacharyyaJoseph Davar
Jun 30, 2009·Nature Reviews. Clinical Oncology·Sanjeev BhattacharyyaMartyn E Caplin
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catharina M KorseJohannes M G Bonfrer
Nov 19, 2009·Circulation. Cardiovascular Imaging·Sanjeev BhattacharyyaJoseph Davar
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David L BushnellStanislas A Pauwels
May 25, 2010·The American Journal of Cardiology·Nicolas MansencalOlivier Dubourg
Aug 20, 2010·Neuroendocrinology·Deidi Strickland BergestuenEspen Thiis-Evensen
Oct 12, 2010·Future Cardiology·Shahzad G RajaGilles D Dreyfus
Nov 6, 2010·Journal of Cardiovascular Computed Tomography·Prabhakar RajiahPaul Schoenhagen
Nov 5, 2011·Gut·John K RamageUNKNOWN UK and Ireland Neuroendocrine Tumour Society
Feb 9, 2012·Cardiology in Review·Chandrasekar PalaniswamyWilbert S Aronow
Aug 21, 2013·Current Treatment Options in Cardiovascular Medicine·J Wells Askew, Heidi M Connolly
Jan 18, 2014·Seminars in Interventional Radiology·Sanjay Gupta
Jul 12, 2014·The New England Journal of Medicine·Martyn E CaplinUNKNOWN CLARINET Investigators
Jan 31, 2015·The Journal of Clinical Endocrinology and Metabolism·Marianne PavelBertram Wiedenmann
Apr 15, 2015·Neuroendocrinology·Simona Grozinsky-GlasbergDavid J Gross
Nov 14, 2015·Journal of the American College of Cardiology·Heidi M ConnollyPatricia A Pellikka
May 24, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Aaron I VinikUNKNOWN ELECT Study Group *
Dec 6, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew H KulkeMarianne Pavel
Jan 12, 2017·The New England Journal of Medicine·Jonathan StrosbergUNKNOWN NETTER-1 Trial Investigators
Mar 11, 2017·Journal of the American College of Cardiology·Joseph DavarChristos Toumpanakis
Jan 14, 2018·Endocrine-related Cancer·Marianne PavelRocio Garcia-Carbonero
Jun 20, 2018·Clinical Nuclear Medicine·Saurabh AroraChandrasekhar Bal
Aug 12, 2018·Journal of Clinical Anesthesia·Michelle A O KinneyDavid P Martin
Sep 6, 2018·Brazilian Journal of Cardiovascular Surgery·Syed Saleem Mujtaba, Stephen Clark

❮ Previous
Next ❯

Citations

Apr 20, 2021·Bulletin du cancer·Serena PulciniMaxime Fontanilles

❮ Previous
Next ❯

Methods Mentioned

BETA
urine collection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Tais De JesusPatricia A Pellikka
Journal of the American College of Cardiology
Heidi M ConnollyPatricia A Pellikka
Journal of Cardiac Surgery
Anders Albåge, Marco Montibello
© 2021 Meta ULC. All rights reserved